GlassScriptPhysician profile
Anju Bhardwaj
NPI 1881803070
$11,097.02
in general payments reported to CMS, 2019-2025
21 companies · $1,001 in 2025
The $1,001 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $430 · 2021: $4,641 · 2022: $1,047 · 2023: $2,530 · 2024: $1,055 · 2025: $1,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,637 · Travel and Lodging: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,636.68 |
| Travel and Lodging | $949.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $3,759.34 | 2021-2023 | Onpattro |
| Impulse Dynamics (USA) INC. | $2,101.05 | 2021-2025 | Optimizer, Optimizer |
| Abbott Laboratories | $1,969.27 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Cardiomems |
| Abiomed | $1,753.53 | 2022-2025 | Impella |
| Actelion Pharmaceuticals US, INC. | $245.57 | 2019-2020 | |
| Cvrx, INC. | $207.62 | 2025 | Barostim Neo System |
| Paragonix Technologies, INC. | $160.04 | 2024 | |
| United Therapeutics Corporation | $152.69 | 2020 | |
| Medtronic, INC. | $144.67 | 2021-2025 | Avalus |
| Allergan, INC. | $124.99 | 2019 | |
| Daiichi Sankyo INC. | $120.23 | 2023 | Enhertu |
| Boston Scientific Corporation | $108.44 | 2019 | |
| Bridgebio Pharma, INC. | $66.94 | 2025 | Attruby |
| Pfizer INC. | $51.77 | 2025 | |
| Analog Devices INC. | $24.95 | 2025 | Sensinel Cpm Wearable |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $24.89 | 2023 | Zio Xt Patch |
| Astrazeneca Pharmaceuticals LP | $21.97 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.54 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $18.30 | 2024 | |
| Medtronic Vascular, INC. | $16.78 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anju Bhardwaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.